home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

How to Monitor Pharmaceutical, Biologic and Medical Device Clinical Trials for GCP Compliance

 
  January 05, 2012  
     
 
Center for Professional Innovation & Education (CfPIE), King of Prussia, PA
April 2 & 3, 2012


This course will benefit those involved in the monitoring and/or QA of clinical trials.  Upon completion, attendees will be able to identify and define the requirements for GCPs and define the basic roles and responsibilities of sponsor, monitor, investigators and FDA as they relate to the quality of clinical trials.  Additionally, the course will detail the similarities and differences in GCPs for drug, device, and biologic studies.  Other related issues, such as documentation requirements, data compliance mandates and informed consent protocols will be comprehensively covered.  Participants will also learn to apply what they have learned to proactively prevent fraud and misconduct in clinical trials.
 
 
Organized by: Center for Professional Innovation & Education
Invited Speakers: Contact info@cfpie.com for a list of course instructors
 
Deadline for Abstracts: n/a
 
Registration: http://www.cfpie.com/showitem.aspx?productid=043&source=hummolgen
E-mail: info@cfpie.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.